Effect of different obesity phenotypes on cardiovascular events in Tehran lipid and glucose study (TLGS)

American Journal of Cardiology

Volumn 107, Issue 3, 2011, Pages 412-416

  Hosseinpanah, Farhad ^a   Barzin, Maryam ^a   Sheikholeslami, Farhad ^b   Azizi, Fereidoun ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LIPID;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; OBESITY; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY;

BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; URBAN POPULATION;

EID: 78951479474     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.09.034     Document Type: Article

References (29)

1. G. Whitlock, S. Lewington, P. Sherliker, R. Clarke, J. Emberson, J. Halsey, N. Qizilbash, R. Collins, and R. Peto Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies Lancet 373 2009 1083 1096
2. E.A. Molenaar, S.J. Hwang, R.S. Vasan, D.E. Grobbee, J.B. Meigs, R.B. D'Agostino Sr, D. Levy, and C.S. Fox Burden and rates of treatment and control of cardiovascular disease risk factors in obesity: the Framingham Heart Study Diabetes Care 31 2008 1367 1372
3. S. Kenchaiah, J.M. Gaziano, and R.S. Vasan Impact of obesity on the risk of heart failure and survival after the onset of heart failure Med Clin North Am 88 2004 1273 1294
4. J.B. Meigs, P.W. Wilson, C.S. Fox, R.S. Vasan, D.M. Nathan, L.M. Sullivan, and R.B. D'Agostino Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease J Clin Endocrinol Metab 91 2006 2906 2912
5. N.B. Ruderman, P. Berchtold, and S. Schneider Obesity-associated disorders in normal-weight individuals: some speculations Int J Obes 6 suppl 1982 151 157
6. R.P. Wildman, P. Muntner, K. Reynolds, A.P. McGinn, S. Rajpathak, J. Wylie-Rosett, and M.R. Sowers The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 19992004) Arch Intern Med 168 2008 1617 1624
7. F. Hadaegh, A. Zabetian, H. Harati, and F. Azizi Metabolic syndrome in normal-weight Iranian adults Ann Saudi Med 27 2007 18 24
8. S. Klein, D.B. Allison, S.B. Heymsfield, D.E. Kelley, R.L. Leibel, C. Nonas, and R. Kahn Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association Obesity (Silver Spring) 15 2007 1061 1067
9. Y. Song, J.E. Manson, J.B. Meigs, P.M. Ridker, J.E. Buring, and S. Liu Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women Am J Cardiol 100 2007 1654 1658
10. K.E. Kip, O.C. Marroquin, D.E. Kelley, B.D. Johnson, S.F. Kelsey, L.J. Shaw, W.J. Rogers, and S.E. Reis Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study Circulation 109 2004 706 713
11. A. Romero-Corral, V.K. Somers, J. Sierra-Johnson, Y. Korenfeld, S. Boarin, J. Korinek, M.D. Jensen, G. Parati, and F. Lopez-Jimenez Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality Eur Heart J 31 2009 737 746
12. M.P. St-Onge, I. Janssen, and S.B. Heymsfield Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual Diabetes Care 27 2004 2222 2228
13. A.J. Scheen Progression of the prevalence of metabolic syndrome in normal-weight US subjects Arch Intern Med 169 2009 636 637
14. F. Irie, H. Iso, H. Noda, T. Sairenchi, E. Otaka, K. Yamagishi, M. Doi, Y. Izumi, and H. Ota Associations between metabolic syndrome and mortality from cardiovascular disease in Japanese general population, findings on overweight and non-overweight individuals Ibaraki Prefectural Health Study Circ J 73 2009 1635 1642
15. D. Zhao, S.M. Grundy, W. Wang, J. Liu, Z. Zeng, and Z. Wu Ten-year cardiovascular disease risk of metabolic syndrome without central obesity in middle-aged Chinese Am J Cardiol 100 2007 835 839
16. F. Azizi, A. Ghanbarian, A.A. Momenan, F. Hadaegh, P. Mirmiran, M. Hedayati, Y. Mehrabi, and S. Zahedi-Asl Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II Trials 10 2009 15
17. F. Azizi, M. Rahmani, H. Emami, P. Mirmiran, R. Hajipour, M. Madjid, J. Ghanbili, A. Ghanbarian, Y. Mehrabi, N. Saadat, P. Salehi, N. Mortazavi, P. Heydarian, N. Sarbazi, S. Allahverdian, N. Saadati, E. Ainy, and S. Moeini Cardiovascular risk factors in an Iranian urban population: Tehran Lipid and Glucose Study (phase 1) Soz Praventivmed 47 2002 408 426
18. F. Hadaegh, H. Harati, A. Ghanbarian, and F. Azizi Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study Eur J Cardiovasc Prev Rehabil 13 2006 571 577
19. A. Delavari, M.H. Forouzanfar, S. Alikhani, A. Sharifian, and R. Kelishadi First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran Diabetes Care 32 2009 1092 1097
20. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
21. B.E. Ainsworth, D.R. Jacobs Jr, and A.S. Leon Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire Med Sci Sports Exerc 25 1993 92 98
22. E.E. Calle, M.J. Thun, J.M. Petrelli, C. Rodriguez, and C.W. Heath Jr Body-mass index and mortality in a prospective cohort of U.S. adults N Engl J Med 341 1999 1097 1105
23. B. Teucher, S. Rohrmann, and R. Kaaks Obesity: focus on all-cause mortality and cancer Maturitas 65 2010 112 116
24. T. Yatagai, S. Nagasaka, A. Taniguchi, M. Fukushima, T. Nakamura, A. Kuroe, Y. Nakai, and S. Ishibashi Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus Metabolism 52 2003 1274 1278
25. E.E. Kershaw, and J.S. Flier Adipose tissue as an endocrine organ J Clin Endocrinol Metab 89 2004 2548 2556
26. H. Nagaretani, T. Nakamura, T. Funahashi, K. Kotani, M. Miyanaga, K. Tokunaga, M. Takahashi, H. Nishizawa, K. Kishida, H. Kuriyama, K. Hotta, S. Yamashita, and Y. Matsuzawa Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance Diabetes Care 24 2001 2127 2133
27. M.C. Pouliot, J.P. Despres, A. Nadeau, S. Moorjani, D. Prud'Homme, P.J. Lupien, A. Tremblay, and C. Bouchard Visceral obesity in men Associations with glucose tolerance, plasma insulin, and lipoprotein levels Diabetes 41 1992 826 834
28. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies Lancet 363 2004 157 163
29. J.B. Meigs, M.G. Larson, R.B. D'Agostino, D. Levy, M.E. Clouse, D.M. Nathan, P.W. Wilson, and C.J. O'Donnell Coronary artery calcification in type 2 diabetes and insulin resistance: the Framingham Offspring Study Diabetes Care 25 2002 1313 1319